New clinical data app harmonizes study data from multiple sources to provide complete, concurrent clinical trial data
BARCELONA, Spain, Oct. 18, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) has announced the availability of Veeva CDB, a pioneering solution for clinical data aggregation, cleansing and transformation. Veeva CDB will evolve the way clinical data management teams work by providing a platform for the ingestion and review of all study data sources, while reducing manual processes, integration projects, complexity and costs. associated with the use of data from clinical trials.
With Veeva CDB, sponsors and data providers can centrally view and resolve data queries to minimize quality risks, provide better data visibility, and speed trial execution. Veeva CDB's automated ingestion engine pulls together data from a wide range of external sources, including EDC, RTSM, ePRO, eCOA, and lab data. Introduction from the Veeva Vault EDC is available today, and support for other third-party EDC systems, including Medidata Rave™, is planned for 2023.
"With the rise of digital data sources in clinical trials, effective data management has become a key factor in study success," said Mayank Anand, vice president and global head of data strategy and management at GSK. "Veeva CBD speeds up aggregation and cleanup, allowing our data managers to focus on value-added activities that can move our trials forward."
"We have worked closely with 10 clinical trial sponsors and CROs and 18 of their key data providers to develop and refine Veeva CBD over the past two years," said Pavel Burmenko, CEO of Veeva CBD. "In more than 100 trials to date, Veeva CBD has delivered analysis-ready data faster to make more informed decisions and speed execution among all trial partners."
The Veeva CBD Data Provider Program also announced today will bring together, for the first time, sponsors, CROs and data providers on a single clinical data management platform to facilitate the delivery of quality data faster and more efficiently. The program enables qualified data providers to have the tools, training and support to provide data using a standardized and streamlined method for Veeva CBD customers.
"In line with our commitment to enabling evidence generation in modern clinical trials, we are delighted to partner with Veeva to support the data integration needs of our mutual customers," said Ian Jennings, chief commercial officer of Signant Health.
Learn how Veeva CDB transforms the role of the data steward and delivers faster insights on the Veeva R
Additional Information
For more information about Veeva CBD, visit: veeva.com/eu/CDB Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu
About Veeva Systems
Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit the website veeva.com/eu.
Veeva Forward Looking Statements
This release contains forward-looking statements about Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update any such statements. There are numerous risks that may adversely affect our results, including the risks and uncertainties set forth in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (on pages 39-40). a summary of risks that may affect our business), and in our subsequent filings with the SEC, which you can access at sec.gov.
© 2022 Veeva Systems Inc. All rights reserved. Veeva, V, Vault and Crossix are registered trademarks of Veeva Systems Inc. All third-party trademarks (including logos and icons) referenced in this document are the property of their respective owners. The use of them does not imply any affiliation or approval by them.
Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/aplicacion-veeva-cdb-para-agilizar-la-agregacion-limpieza-y-transformacion-de-datos-clinicos-301651905.html
